Skip to content
2000
Volume 10, Issue 2
  • ISSN: 1573-4021
  • E-ISSN: 1875-6506

Abstract

Hypertension is often difficult to control in patients with chronic kidney disease. Clinicians often view thiazide and thiazide-like diuretics as being ineffective in reducing blood pressure in patients with chronic kidney disease, and prefer to use loop diuretics, especially if the estimated glomerular filtration rate (eGFR) is below 50 ml/min/1.73m2. Recent clinical trial data indicate that thiazide and thiazide-like diuretics possess important and clinically significant antihypertension properties, that are likely independent of volume reduction, even in patients with eGFR in the 15-45 ml/min range. Thiazide and thiazide-like diuretics should be given consideration for use in the treatment of hypertension in patients with chronic kidney disease, especially if there is no clinical evidence of volume overload.

Loading

Article metrics loading...

/content/journals/chyr/10.2174/1573402111666141231150213
2014-06-01
2025-10-01
Loading full text...

Full text loading...

/content/journals/chyr/10.2174/1573402111666141231150213
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test